BioSpace News Archive

Pharming Announces Warrant Exercises and Conversions of Its Ordinary Bonds Into Shares Mostly Through Cashless Exercise

Pharming Group N.V. announced that since the release of its update regarding cashless and other warrant exercises and bond conversions on 10 August 2017.

October 23, 2017

·

5 min read

Biotech Bay

Natus to be Exclusive U.S. Agent for the First Neonatal MRI Device

The Embrace Neonatal MRI System is designed specifically for imaging of the neonatal head.

October 23, 2017

·

2 min read

Business

Strong Cresemba (Isavuconazole) Sales in The United States Trigger First Sales Milestone Payment to Basilea

Under the agreement, Basilea is still eligible for additional sales milestone payments of up to CHF 285 million in addition to tiered, double-digit royalties on U.S. sales.

October 23, 2017

·

3 min read

Pharm Country

QPharma Introduces CRM System for Life Sciences

QPharma, a premier provider of commercial and compliance services to the life sciences industry, has announced the launch of Ti Force, a new, cloud-based mobile CRM system developed specifically for the life sciences industry.

October 23, 2017

·

2 min read

TESARO Announces U.S. FDA Approval of VARUBI IV fo

FDA

Impax Announces FDA Approval and Launch of Generic Renvela (Sevelamer Carbonate) Tablets, 800 mg

Impax received final FDA approval on its ANDA for a generic version of Renvela (sevelamer carbonate) tablets, 800 mg.

October 23, 2017

·

6 min read

Biotech Beach

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

Arrowhead Pharmaceuticals announced that as an inducement to entering into employment with the Company, on October 17, 2017, eight new employees were awarded “inducement” grants of options under Rule 5635(c)(4) of the NASDAQ Marketplace Rules.

October 23, 2017

·

2 min read

Biotech Beach

Neurocrine Granted FDA Orphan Drug Designation for Valbenazine for the Treatment of Pediatric Patients With Tourette Syndrome

Neurocrine today announced that valbenazine, a novel selective vesicular monoamine transporter 2 (VMAT2), has been granted Orphan Drug Designation by the FDA for the treatment of pediatric patients with Tourette syndrome.

October 23, 2017

·

6 min read

Drug Development

Transgene Release: TG1050 is Well Tolerated and Induces a Strong Specific Immune Response in Patients with Chronic Hepatitis B

Transgene announces that the analyses conducted on patients with chronic hepatitis B receiving standard antiviral therapies and a single dose of TG1050 in the Phase I/Ib trial, confirm the good tolerability profile and demonstrate the immunogenicity of this novel therapeutic vaccine.

October 23, 2017

·

6 min read

Drug Development

Angle PLC: Researchers Develop Parsortix-Based Process to Efficiently Harvest Cancer Cells From Bone Marrow

ANGLE plc., a world-leading liquid biopsy company, today announces that the Center for Women’s Health Tuebingen, Germany, has presented the first report on a successful establishment of a protocol for detecting disseminated tumour cells (DTCs) using cancer patient bone marrow with the Parsortix system.

October 23, 2017

·

6 min read

Drug Development

Medivir Release: Data on the Clinical Activity of Simeprevir in Combination With AL-335 and Odalasvir (JNJ-4178) Presented at the 2017 Liver Meeting™

Medivir today communicates phase IIb data on JNJ-4178, the triple combination consisting of simeprevir, odalasvir and AL-335, following presentations at the 2017 AASLD and held in Washington DC on 20-24 October.

October 23, 2017

·

2 min read